AbbVie reported a 9% stake in Xilio Therapeutics XLO · 4,347,826 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 9%
Last report: First report
Shares held: 4,347,826 sh
Class: Common Stock, par value $0.0001 per share
Stock: Xilio Therapeutics XLO
Holder: AbbVie
Event date: 25/02/11
Filed: 25/02/18

First 5%+ report · 9% stake

Xilio Therapeutics trades, last 26 weeks

What else happened in Xilio Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/12~25/03/13

AbbVie's other 5% stake reports

No other trades yet.